{rfName}

Indexed in

License and use

Altmetrics

Grant support

This work was funded by Sociedad Espanola de Endocrinologia y Nutricion (SEEN) https://www.seen.es/portal.

Analysis of institutional authors

González Boillos MAuthorRebollo Román áAuthorMorales MAuthorHanzu FAuthor
Share
Publications
>
Article

Differences in the presentation and evolution of primary aldosteronism in elderly (≥65 years) and young patients (<65 years)

Publicated to:Endocrine Connections. 11 (6): EC-0169 - 2022-06-01 11(6), DOI: 10.1530/ec-22-0169

Authors: Parra Ramirez, Paola; Martin Rojas-Marcos, Patricia; Paja Fano, Miguel; Gonzalez Boillos, Marga; Pascual-Corrales, Eider; Garcia-Cano, Ana; Gabriel Ruiz-Sanchez, Jorge; Vicente, Almudena; Gomez-Hoyos, Emilia; Ferreira, Rui; Garcia Sanz, Inigo; Recasens, Monica; Pla Peris, Begona; Barahona San Millan, Rebeca; Picon Cesar, Maria Jose; Diaz Guardiola, Patricia; Garcia Gonzalez, Juan Jesus; Perdomo, Carolina; Manjon, Laura; Garcia-Centeno, Rogelio; Carlos Percovich, Juan; Rebollo Roman, Angel; Gracia Gimeno, Paola; Robles Lazaro, Cristina; Morales, Manuel; Hanzu, Felicia; Araujo-Castro, Marta

Affiliations

Biochemistry Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. - Author
CiberOBN, Madrid, Spain - Author
CIBEROBN, Madrid, Spain. - Author
Clin Univ Navarra, Endocrinol & Nutr Dept, Pamplona, Spain - Author
Complejo Hosp Malaga Hosp Virgen de la Victoria, Endocrinol & Nutr Dept, IBIMA Malaga, Malaga, Spain - Author
Complejo Univ Toledo, Endocrinol & Nutr Dept, Toledo, Spain - Author
Endocrinology & Nutrition Department, Clínica Universidad de Navarra, Pamplona, Spain. - Author
Endocrinology & Nutrition Department, Hospital Clinic, Barcelona, Spain. - Author
Endocrinology & Nutrition Department, Hospital Reina Sofía, Córdoba, Spain. - Author
Endocrinology & Nutrition Department, Hospital Universitario Central de Asturias, Oviedo, Spain. - Author
Endocrinology & Nutrition Department, Hospital Universitario de Castellón, Castellón, Spain. - Author
Endocrinology & Nutrition Department, Hospital Universitario de La Princesa, Madrid, Spain. - Author
Endocrinology & Nutrition Department, Hospital Universitario Infanta Sofía, Madrid, Spain. - Author
Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. - Author
Endocrinology & Nutrition Department, Hospital Universitario Virgen de la Macarena, Sevilla, Spain. - Author
General & Digestive Surgery Department, Hospital Universitario de La Princesa, Madrid, Spain. - Author
Hosp Clin Barcelona, Biochem & Mol Genet Dept CDB, CIBERehd, IDIBAPS, Barcelona, Spain - Author
Hosp Clin Barcelona, Endocrinol & Nutr Dept, Barcelona, Spain - Author
Hosp Clin Univ Valladolid, Endocrinol & Nutr Dept, Valladolid, Spain - Author
Hosp Fdn Jimenez Diaz, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Gen Univ Gregorio Maranon, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Josep Trueta, Endocrinol & Nutr Dept, Serv Endocrinol, Girona, Spain - Author
Hosp Reina Sofia, Endocrinol & Nutr Dept, Cordoba, Spain - Author
Hosp Royo Villanova, Endocrinol & Nutr Dept, Zaragoza, Spain - Author
Hosp Univ Basurto, Endocrinol & Nutr Dept, Bilbao, Spain - Author
Hosp Univ Castellon, Endocrinol & Nutr Dept, Castellon de La Plana, Spain - Author
Hosp Univ Cent Asturias, Endocrinol & Nutr Dept, Oviedo, Spain - Author
Hosp Univ Infanta Sofia, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Univ La Princesa, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Univ La Princesa, Gen & Digest Surg Dept, Madrid, Spain - Author
Hosp Univ Ramon y Cajal, Biochem Dept, Madrid, Spain - Author
Hosp Univ Ramon y Cajal, Endocrinol & Nutr Dept, Madrid, Spain - Author
Hosp Univ Salamanca, Endocrinol & Nutr Dept, Salamanca, Spain - Author
Hosp Univ Virgen de la Macarena, Endocrinol & Nutr Dept, Seville, Spain - Author
Inst Invest Biomed Ramon y Cajal IRYCIS, Madrid, Spain - Author
Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain - Author
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain. - Author
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain. - Author
La Paz Univ Hosp, Endocrinol & Nutr Dept, Madrid, Spain - Author
Univ Alcala, Madrid, Spain - Author
Univ Basque Country, Med Dept, Bilbao, Spain - Author
See more

Abstract

Objective: To compare the presentation and evolution of primary aldosteronism (PA) in the elderly (?65 years) and young patients (<65 years). Methods: A retrospective multicenter study was performed in 20 Spanish hospitals of PA patients in follow-up between 2018 and 2021. Results: Three hundred fifty-two patients with PA <65 years and 88 patients ?65 years were included. Older PA patients had a two-fold higher prevalence of type 2 diabetes, dyslipidemia, and cerebrovascular disease, but these differences disappeared after adjusting for hypertension duration. At diagnosis, diastolic blood pressure was lower than in young patients (83.3 ± 11.54 vs 91.6 ± 14.46 mmHg, P < 0.0001). No differences in the rate of overall correct cannulation (56.5% vs 42.3%, P = 0.206) or the diagnosis of unilaterality (76.9% vs 62.5%, P = 0.325) in the adrenal venous sampling (AVS) was observed between the elderly and young groups. However, there was a lower proportion of PA patients who underwent adrenalectomy in the elderly group than in the younger group (22.7% (n = 20) vs 37.5% (n = 132), P = 0.009). Nevertheless, no differences in the rate of postsurgical biochemical (100% (n = 14) vs 92.8% (n = 90), P = 0.299) and hypertension cure (38.6% (n = 51) vs 25.0% (n = 5), P = 0.239) were observed between both groups. Conclusion: Older patients with PA have a worse cardiometabolic profile than young patients with PA that it is related to a longer duration of hypertension. However, the results of the AVS, and adrenalectomy are similar in both groups. Therefore, the management of elderly patients with PA should be based not only on age, but rather on the overall medical, physical, social, and mental characteristics of the patients. © 2022 The authors Published by Bioscientifica Ltd.

Keywords
adrenal venous samplingadrenalectomyblood-pressureconsensusdiagnosiselderlyhypertensionmanagementoutcomesprevalenceAdolescentAdrenal venous samplingAdrenalectomyAdultAgedAldosteroneAlpha adrenergic receptor blocking agentAntihypertensive agentArticleBeta adrenergic receptor blocking agentBiochemical analysisBody massCalcium channel blocking agentCannulationCaptoprilCerebrovascular diseaseChildChronic kidney failureComputed tomographic angiographyControlled studyCorticotropinDemographicsDiabetes mellitusDiastolic blood pressureDiuretic agentDyslipidemiaElderlyEuropean-societyFemaleFollow upGlucocorticoidHumanHypertensionHypokalemiaMajor clinical studyMaleMiddle agedMulticenter studyNon insulin dependent diabetes mellitusPlasma renin activityPostoperative complicationPrevalencePrimary aldosteronismPrimary hyperaldosteronismRetrospective studySleep disordered breathingYoung adult

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Endocrine Connections due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position , thus managing to position itself as a Q2 (Segundo Cuartil), in the category Internal Medicine. Notably, the journal is positioned en el Cuartil Q3 for the agency WoS (JCR) in the category Endocrinology & Metabolism.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 3.74, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-15, the following number of citations:

  • WoS: 7
  • Scopus: 6
  • Europe PMC: 3
  • OpenCitations: 6
Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-15:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 16.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 16 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 15.55.
  • The number of mentions on the social network X (formerly Twitter): 28 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.